Daiichi Sankyo: Clinical Trials & Research Profile

Biopharma Industry (Tokyo, JP / Basking Ridge, NJ) · Primary Focus: Oncology and Hematology

Clinical Trial MetricVerified Public Record
Organization TypeConsolidated Trial Sponsor
Institutional Sector & LocationBiopharma Industry (Tokyo, JP / Basking Ridge, NJ)
Primary Therapeutic AreaOncology and Hematology
Active Phase II & III Studies39 active (20 recruiting now)
Total Tracked Studies (2018 to 2026)60 (30 with California sites)
Completed vs Early-Stopped Studies17 completed / 4 stopped (6.7% stop rate)
Median Closed Enrollment162 participants
FDA Drugs@FDA Original Approvals6 all-time (5 from 2018 to 2026)
Physical Hospital Site Disclosure97.5% named hospital slots

Related Filings Across Meru Platforms

Verified cross-ledger federal filings for Daiichi Sankyo across sibling Meru public-data platforms.

Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI -> · AI for Healthcare · Healthcare Price & Patent Cliff Crosswalk